These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35266258)

  • 41. Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
    Huynh LM; Bonebrake BT; DiMaio DJ; Baine MJ; Teply BA
    Medicine (Baltimore); 2021 Dec; 100(49):e28199. PubMed ID: 34889301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concise review of lichen planus and lichenoid dermatoses.
    Pickert A
    Cutis; 2012 Sep; 90(3):E1-3. PubMed ID: 24005806
    [No Abstract]   [Full Text] [Related]  

  • 43. [Lichen pemphigoid associated with developing hepatitis B in a child].
    Flageul B; Hassan F; Pinquier L; Blanchet-Bardon C; Dubertret L
    Ann Dermatol Venereol; 1999; 126(8-9):604-7. PubMed ID: 10530348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bullous lichen planus and lichen planus pemphigoides--clinico-pathological comparisons.
    Gawkrodger DJ; Stavropoulos PG; McLaren KM; Buxton PK
    Clin Exp Dermatol; 1989 Mar; 14(2):150-3. PubMed ID: 2598489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade Therapy.
    Ameri AH; Foreman RK; Vedak P; Chen S; Miller DM; Demehri S
    Oncologist; 2020 May; 25(5):366-368. PubMed ID: 32073194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lichen planus pemphigoides induced by a weight reduction drug.
    Rosmaninho A; Sanches M; Oliveira A; Alves R; Selores M
    Cutan Ocul Toxicol; 2011 Dec; 30(4):306-8. PubMed ID: 21428725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Coexistence of lichen planus and bullous pemphigoid (an immunofluorescence study of a "lichen pemphigoides") (author's transl)].
    Saurat JH; Guinepain MT; Didierjean L; Sohier J; Puissant A
    Ann Dermatol Venereol; 1977 May; 104(5):368-74. PubMed ID: 72516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lichen planus associated with milia.
    Lucke T; Fallowfield M; Burden D
    Clin Exp Dermatol; 1999 Jul; 24(4):266-9. PubMed ID: 10457126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lichen planus pemphigoides: case report and results of immunofluorescence and immunoelectron microscopic study.
    Okochi H; Nashiro K; Tsuchida T; Seki Y; Tamaki K
    J Am Acad Dermatol; 1990 Apr; 22(4):626-31. PubMed ID: 2180994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies.
    Tziotzios C; Brier T; Lee JYW; Saito R; Hsu CK; Bhargava K; Stefanato CM; Fenton DA; McGrath JA
    J Am Acad Dermatol; 2018 Nov; 79(5):807-818. PubMed ID: 30318137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report.
    Manko S; Côté B; Provost N
    SAGE Open Med Case Rep; 2021; 9():2050313X21993279. PubMed ID: 33747513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nivolumab-induced lichenoid reaction in a patient with advanced renal cancer.
    Martínez Del Sel J; Benítez N; Allevato M
    Int J Dermatol; 2021 Oct; 60(10):e397-e398. PubMed ID: 34363614
    [No Abstract]   [Full Text] [Related]  

  • 53. Checkpoint inhibitor-induced lichen planus pemphigoides: a case report and literature review of an unusually reported entity.
    Buján Bonino C; López-Pardo Rico M; Moreiras Arias N; Suárez Peñaranda JM; Casas Fernández L
    Int J Dermatol; 2023 Apr; 62(4):e200-e204. PubMed ID: 36371713
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral lichenoid drug eruptions: their recognition and management.
    Rice PJ; Hamburger J
    Dent Update; 2002 Nov; 29(9):442-7. PubMed ID: 12494560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical evolution of lichen planus pemphigoides.
    Alkul M; Truitt J; Tarbox MB
    Proc (Bayl Univ Med Cent); 2022; 35(3):352-353. PubMed ID: 35518823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Erythrodermic lichen planus pemphigoides].
    Campos-Domínguez M; Silvente C; de la Cueva P; González-Carrascosa M; Lecona M; Suárez R; Lázaro P
    Actas Dermosifiliogr; 2006 Nov; 97(9):583-6. PubMed ID: 17173763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors.
    Alharbi A; Khobrani A; Noor A; Alghamdi W; Alotaibi A; Alnuhait M; Haseeb A
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications.
    Maul JT; Guillet C; Oschmann A; Maul LV; Meier-Schiesser B; Stadler PC; French LE; Kerl K
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):965-975. PubMed ID: 36652271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ulcerated Lichen Planus after Adjuvant Use of Programmed Cell Death-1-Inhibitor: A Case Report and Systematic Review of the Literature.
    Niesert AC; Guertler A; Schutti O; Engels L; Flaig M; French LE; Schlaak M; Reinholz M
    Acta Derm Venereol; 2021 Jun; 101(6):adv00472. PubMed ID: 34043014
    [No Abstract]   [Full Text] [Related]  

  • 60. Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies.
    Carrozzo M; Porter S; Mercadante V; Fedele S
    Periodontol 2000; 2019 Jun; 80(1):105-125. PubMed ID: 31090143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.